首頁 › 非小細胞肺癌 › 康乃狄克 › Bridgeport
Bridgeport, CT 的 非小細胞肺癌 臨床試驗
14 項針對 非小細胞肺癌 的研究正在 Bridgeport（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距離 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距離 5 英里
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- Smilow Cancer Hospital - Trumbull, Trumbull · 距離 4 英里
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
招募中3 期
- University Hospital at Stony Brook ( Site 0054), Stony Brook · 距離 18 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Stony Brook · 距離 18 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Suny-Stony Brook University Cancer Center, Stony Brook · 距離 18 英里
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 距離 19 英里
- New york cancer and blood specialists - Oncology, Port Jefferson Station · 距離 19 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Port Jefferson Station · 距離 19 英里
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
招募中1/2 期
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 距離 4 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距離 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距離 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距離 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距離 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距離 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距離 5 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 距離 4 英里
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 距離 5 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Bridgeport 的其他研究
- 乳癌21 項研究
- 肺癌13 項研究
- 急性髓系白血病12 項研究
- 心血管疾病9 項研究
- 癌症（所有類型）8 項研究
- 頭頸部鱗狀細胞癌8 項研究
- 轉移性癌症7 項研究
- 心臟衰竭7 項研究
- 腦動脈瘤6 項研究
- 多發性骨髓瘤6 項研究
- 前列腺癌6 項研究
- 卵巢癌5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。